Dr. Paul Ziemer as Director of EKO and president of NeuroVasc Clinical Inc. called into SmallCapVoice.com to go over the business model, market, recent news and opportunities for both companies in the massive diabetes market in North America. EKO International Corp.
EKO International Corp. (Pink Sheets – EKNL) is a holding company focused on growth through acquisition. Each acquisition must have substantial growth potential and is expected to add assets and/or cash-flow to the consolidated financial statements of the Company. The Company is willing to examine a variety of proposed target businesses and if interested, will negotiate terms and conditions of purchase favorable to itself.